MedTrace Logo

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

NCT06611033 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2026-01-20

No results posted yet for this study

Summary

The goal of this study is to learn how safe V118 Formulation C is in Healthy Adults and how well people tolerate it.

Conditions

  • Healthy

Interventions

BIOLOGICAL

V118C

Intramuscular Administration

BIOLOGICAL

V118

Intramuscular Administration

BIOLOGICAL

PREVNAR 20™

Intramuscular Administration

BIOLOGICAL

Saline

Intramuscular Administration

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-25
Primary Completion
2026-01-09
Completion
2026-01-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06611033 on ClinicalTrials.gov